TY  - GEN
AU  - O'Brien,Maureen M
AU  - Lacayo,Norman J
AU  - Lum,Bert L
AU  - Kshirsagar,Smita
AU  - Buck,Steven
AU  - Ravindranath,Yaddanapudi
AU  - Bernstein,Mark
AU  - Weinstein,Howard
AU  - Chang,Myron N
AU  - Arceci,Robert J
AU  - Sikic,Branimir I
AU  - Dahl,Gary V
TI  - Phase I study of valspodar (PSC-833) with mitoxantrone and etoposide in refractory and relapsed pediatric acute leukemia: a report from the Children's Oncology Group
SN  - 1545-5017
PY  - 2010///0407
KW  - ATP Binding Cassette Transporter, Subfamily B, Member 1
KW  - antagonists & inhibitors
KW  - Adolescent
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Child
KW  - Child, Preschool
KW  - Cyclosporins
KW  - administration & dosage
KW  - Drug Resistance, Multiple
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Etoposide
KW  - Female
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Mitoxantrone
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Recurrence
KW  - Salvage Therapy
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/pbc.22366
ER  -